WHO’s Expert Advisory Group for Immunity (SAGE) announced that a single dose of HPV vaccine provides adequate protection against cervical cancer. With this statement, SAGE also disabled all previous guidelines on the vaccine.
Protection against diseases caused by the sexually transmitted human papillon virus (HPV) is possible with vaccines developed today. However, cervical cancer in women and causes 300,000 women to die each year. The effectiveness of vaccines developed against the virus continued to be a matter of debate.
Today it is affiliated with the World Health Organization. Expert Advisory Group for Immunity (SAGE)shared the latest data on the effectiveness of the HPV vaccine after the meetings where research on vaccine efficacy was evaluated. assessment shared by the group, especially warning message to women drank.
One dose of vaccine is enough
SAGE, in its shared assessment A single dose of HPV vaccine provides adequate protection against cervical cancer. announced their conclusion. Saying that the result of the research is ‘game-changer’, SAGE explained that by demonstrating the effect of single dose use, more people in middle and low-income countries will be able to access the vaccine.
SAGE, with its new statement, It also disabled the previous instructions. Earlier guidelines recommended 2 doses of HPV vaccine to children, teens, and adult women.
Within the scope of the ‘Global Strategy to Accelerate the Elimination of Cervical Cancer’ program, WHO aims to have 90% of women in the world be vaccinated against HPV and 70% to be screened for cancer.
RELATED NEWS
It Was Discovered That High Coffee Consumption May Reduce the Risk of Uterine Cancer
Source :
https://www.aa.com.tr/tr/saglik/dso-tek-doz-hpv-asisi-rahim-agzi-kanserini-onlenen-icin-yeterli/2561260